Skip to main content
SpringerLink
Log in

Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia

  • Comment
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Since dopamine (DA) has been implicated in the inhibitory control of both TSH and LH, we have compared TSH and LH levels following dopamine (DA) receptor blockade with domperidone in patients with hyperprolactinemia due to presumed prolactinomas. Eight euthyroid patients (aged 19-37 yr) with presumed prolactinomas each received domperidone (10 mg iv) at 11: 00 and 23: 00 h and tests were separated by at least one week. Basal TSH levels were significantly greater at 23: 00 than at 11: 00 h (2.7 ± 0.5 vs 1.7 ± 0.4 mU/l, mean ± SE, p < 0.01 ) whereas basal LH levels did not differ. All subjects showed clear rises in basal TSH levels following drug administration and these were significantly greater at 23: 00 than at 11: 00 h (p < 0.02 at each time point). In contrast there was no alteration in LH levels following drug administration at either time of day. These data suggest that the mechanisms underlying the dopaminergic control of TSH and LH are different in these patients. Furthermore the data argue against an anterior pituitary or median eminence site of action of DA in the inhibition of LH release in hyperprolactinemia since domperidone does not penetrate the blood brain barrier to any appreciable extent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Burrow G.N., May P.B., Spaulding S.W., Donabedian R.K. TRH and dopamine interactions affecting pituitary hormone secretion. J. Clin. Endocrinol. Metab. 45: 65, 1977.

    Article  PubMed  CAS  Google Scholar 

  2. Scanlon M.F., Weightman D.R., Shale D.J., Mora V., Heath M., Snow M.H., Lewis M., Hall R. Dopamine is a physiological regulator of thyrotropin (TSH) secretion in normal man. Clin. Endocrinol. (Oxf.) 10: 7, 1979.

    Article  CAS  Google Scholar 

  3. McLeod R.M., Lehmeyer J.D. Studies on the mechanism of the dopamine mediated inhibition of prolactin secretion. Endocrinology 94: 1077, 1974.

    Article  Google Scholar 

  4. Foord S.M., Peters J.R., Dieguez C., Scanlon M.F., Hall R. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin. Endocrinology 112: 1567, 1983.

    Article  PubMed  CAS  Google Scholar 

  5. Judd S.J., Rakoff J.S., Yen S.S.C. Inhibition of gonadotrophin and prolactin release by dopamine: effect of endogenous estradiol levels. J. Clin. Endocrinol. Metab. 47: 494, 1978.

    Article  PubMed  CAS  Google Scholar 

  6. Quigley M.E., Judd S.J., Gilliland G.B., Yen S.S.C. Effects of a dopamine antagonist on the release of gonadotrophin and prolactin in normal women and with hyperprolactinemic anovulation. J. Clin. Endocrinol. Metab. 48: 718, 1979.

    Article  PubMed  CAS  Google Scholar 

  7. Quigley M.E., Yen S.S.C. Evidence for increased dopaminergic inhibition of secretion of thyroid-stimulating hormone in hyperprolactinemic patients with pituitary microadenoma. Am. J. Obstet. Gynecol. 137: 653, 1980.

    PubMed  CAS  Google Scholar 

  8. Scanion M.F., Weetman A.P., Lewis M., Pourmand M., Rodriguez-Arnao M.D., Weightman D.R., Hall R. Dopaminergic modulation of circadian thyrotropin rhythms and thyroid hormone levels in euthyroid subjects. J. Clin. Endocrinol. Metab. 51: 1251, 1980.

    Article  Google Scholar 

  9. Patel Y.C., Alford F.B., Burger H.G. The 24 hour plasma thyrotropin profile. Clin. Sci. Mol. Med. 43: 71, 1972.

    CAS  Google Scholar 

  10. Weeke J. Circadian variation of the serum thyrotropin level in normal subjects. Scand. J. Clin. Lab. Invest. 31: 337, 1973.

    Article  PubMed  CAS  Google Scholar 

  11. Chan V., Jones A., Liendo-Ch P., McNeilly A., Landon J., Besser G.M. The relationship between circadian variations in circulating thyrotrophin, thyroid hormone and prolactin. Clin. Endocrinol. (Oxf.) 9: 337, 1978.

    Article  CAS  Google Scholar 

  12. Cowden E.A., Thomson J.A., Doyle D., Beastall G., Teasdale G. Tests of prolactin secretion in diagnosis of prolactinomas. Lancet 1: 1155, 1979.

    Article  PubMed  CAS  Google Scholar 

  13. Rodriguez-Arnao M.D., Peters J.R., Foord S.M., Dieguez C., Edwards C., Gomez-Pan A., Hah R., Scanion M.F. Exaggerated circadian variation in basal TSH and in the dopaminergic inhibition of TSH release in pathological hyper-prolactinemia-evidence against a hypothalamic dopaminergic effect. J. Clin. Endocrinol. Metab. 57: 975, 1983.

    Article  PubMed  CAS  Google Scholar 

  14. Scanlon M.F., Rodriguez-Arnao M.D., McGregor A.M., Weightman D., Lewis M., Cook D.B., Gomez-Pan A., Hall R. Altered dopaminergic regulation of thyrotropin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function. Clin. Endocrinol. (Oxf.) 14: 133, 1981.

    Article  CAS  Google Scholar 

  15. Reyntjens A.J., Niemegeers C.J.E., Van Neuten J.M., Laduron P., Heykants J., Schellenens K.H.L., Marsboom R., Jageneau A., Brockaert A., Janssen P.A.J. Domperidone, a novel and safe gastrokinetic anti-nauseant for the treatment of dyspepsia and vomiting. Arzneim. Forsch. 28: 1194, 1978.

    CAS  Google Scholar 

  16. EIN R., Scaperotta R.C., Beck-Peccoz P., Travaglini P., Faglia G. Effects of dopaminergic manipulation on serum TSH and LH levels in normal and hyperprolactinemic women. 3rd European Symposium on Pituitary Adenomas, Amsterdam 1983, Abstract P 5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Wales College of Medicine, Heath Park, Cardiff, CF4 4XN, Wales

    J. R. Peters, M. D. Rodriguez-Arnao, S. M. Foord, C. Edwards, C. Dieguez, R. Hall &  M. F. Scanlon

  2. Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, Wales

    S. Woodhead

Authors
  1. J. R. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. D. Rodriguez-Arnao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. M. Foord
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Dieguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Woodhead
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. F. Scanlon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peters, J.R., Rodriguez-Arnao, M.D., Foord, S.M. et al. Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia. J Endocrinol Invest 8, 163–166 (1985). https://doi.org/10.1007/BF03350675

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350675

Key-words

Search

Navigation